UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): April 27, 2017

 

 

Herbalife Ltd.

(Exact name of registrant as specified in its charter)

 

 

 

Cayman Islands   1-32381   98-0377871

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

P.O. Box 309GT, Ugland House,

South Church Street, Grand

Cayman, Cayman Islands

  KY1-1106
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: c/o (213)745-0500

Not Applicable

Former name or former address, if changed since last report

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

Herbalife Ltd. (the “Company”) held its 2017 Annual General Meeting of Shareholders on April 27, 2017 (the “Meeting”). The proposals voted upon at the Meeting and the final results of the shareholder vote on each proposal are set forth below. Each of the proposals is summarized in greater detail in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on March 13, 2017.

(1) Election of directors.

 

     For      Against      Abstain      Broker
Non-votes
 

Michael O. Johnson

     72,900,921        495,740        96,811        8,823,480  

Jeffrey T. Dunn

     73,019,387        354,526        119,559        8,823,480  

Richard P. Bermingham

     72,179,374        1,194,349        119,749        8,823,480  

Pedro Cardoso

     72,443,383        953,064        97,025        8,823,480  

Dr. Richard Carmona

     72,315,720        1,080,558        97,194        8,823,480  

Jonathan Christodoro

     72,090,408        1,282,445        120,619        8,823,480  

Keith Cozza

     72,652,372        720,261        120,839        8,823,480  

Hunter C. Gary

     71,805,634        1,566,314        121,524        8,823,480  

Jesse A. Lynn

     72,709,626        663,812        120,034        8,823,480  

Michael Montelongo

     73,188,234        184,229        121,009        8,823,480  

James L. Nelson

     73,209,604        162,994        120,874        8,823,480  

Maria Otero

     72,081,870        1,290,413        121,189        8,823,480  

John Tartol

     72,308,752        1,087,668        97,052        8,823,480  

(2) Approval, on an advisory basis, of the Company’s executive compensation.

 

For

  Against     Abstain     Broker
Non-votes
 
64,706,766     8,653,368       133,338       8,823,480  

(3) Approval, on an advisory basis, the frequency of shareholder advisory votes on the Company’s executive compensation.

 

1 Year

  2 Year   3 Year     Abstain     Broker
Non-votes
 
73,263,757   52,635     80,100       96,980       8,823,480  

(4) Ratification of the Company’s independent registered public accountants for the Fiscal Year ending December 31, 2017.

 

For

  Against   Abstain     Broker
Non-votes
 
81,863,111   320,158     133,683       —    


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Herbalife Ltd.
May 2, 2017     By:  

/s/ John G. DeSimone

    Name:   John G. DeSimone
    Title:   Chief Financial Officer